Literature DB >> 26421042

What we learned from difficult hepatectomies in patients with advanced hepatic malignancy.

Bo Hyun Jung1, Jae Hoon Lee1, Sang Yeup Lee1, Dae Keun Song1, Ji Woong Hwang1, Dae Wook Hwang1, Young-Joo Lee1, Kwang-Min Park1.   

Abstract

BACKGROUNDS/AIMS: By reviewing difficult resections for advanced hepatic malignancies, we discuss the effectiveness and extended indications for hepatectomy in such patients.
METHODS: We reviewed 7 patients who underwent extensive surgery between July 2008 and March 2011 for advanced hepatic malignancies. They had stage IV disease, except for in one case that was a stage IIIC (T4N0M0) hepatocellular carcinoma (HCC).
RESULTS: Patient 1 with intrahepatic cholangiocarcinoma (IHCC) underwent right hemihepatectomy and resection of the bile duct and left portal vein. At 39 months after surgery, she had no recurrence or metastasis. Patient 2 with HCC underwent palliative right trisectionectomy. At 38 months after surgery, he is alive despite residual pulmonary metastases. Patient 3 with HCC invading the hepatic vein and diaphragm underwent right trisectionectomy and caval venoplasty. At 12 months after surgery, he had no recurrence or metastasis. Patient 4, who had 2 large HCCs and pulmonary thromboembolism, underwent a right trisectionectomy. At 7 months after surgery, he had no evidence of recurred HCC. Patient 5, who had IHCC invading her inferior vena cava and main portal vein, underwent preoperative radiotherapy, left hemihepatectomy, and caval resection. At 20 months after surgery, she is well despite a caval thrombus. Patient 6 and 7 underwent repeated surgery due to a recurred IHCC and metastatic colon cancer, respectively. In addition, they are alive during each 20 and 17 months after surgery.
CONCLUSIONS: Despite macroscopic extrahepatic metastases or major vessel involvement, extensive surgery for advanced hepatic malignancy may result in relatively favorable outcomes and be important modality for improving of survival in such patients.

Entities:  

Keywords:  Hepatectomy; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma

Year:  2011        PMID: 26421042      PMCID: PMC4582463          DOI: 10.14701/kjhbps.2011.15.4.218

Source DB:  PubMed          Journal:  Korean J Hepatobiliary Pancreat Surg        ISSN: 1738-6349


  20 in total

1.  Salvage hepatic resection after incomplete interstitial therapy for primary and secondary liver tumours.

Authors:  G Torzilli; D Del Fabbro; A Palmisano; M Marconi; M Makuuchi; M Montorsi
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

2.  Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.

Authors:  Xiao-Ping Chen; Fa-Zu Qiu; Zai-De Wu; Zhi-Wei Zhang; Zhi-Yong Huang; Yi-Fa Chen; Bi-Xiang Zhang; Song-Qing He; Wan-Guang Zhang
Journal:  Ann Surg Oncol       Date:  2006-05-23       Impact factor: 5.344

3.  Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution.

Authors:  Michael G House; Hiromichi Ito; Mithat Gönen; Yuman Fong; Peter J Allen; Ronald P DeMatteo; Murray F Brennan; Leslie H Blumgart; William R Jarnagin; Michael I D'Angelica
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

4.  Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.

Authors:  Zhao-You Tang; Xin-Da Zhou; Zeng-Chen Ma; Zhi-Quan Wu; Jia Fan; Lun-Xiu Qin; Yao Yu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-11

5.  Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period.

Authors:  Hauke Lang; Georgios C Sotiropoulos; Nils R Frühauf; Marco Dömland; Andreas Paul; Eva-Maria Kind; Massimo Malagó; Christoph E Broelsch
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

6.  Salvage surgery following downstaging of unresectable hepatocellular carcinoma.

Authors:  Wan-yee Lau; Stephen K W Ho; Simon C H Yu; Eric C H Lai; Choong-tsek Liew; Thomas W T Leung
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

Review 7.  Salvage surgery following downstaging of unresectable hepatocellular carcinoma--a strategy to increase resectability.

Authors:  Wan Yee Lau; Eric C H Lai
Journal:  Ann Surg Oncol       Date:  2007-09-22       Impact factor: 5.344

8.  Hepatic resection for bilobar hepatocellular carcinoma: is it justified?

Authors:  Chi-Leung Liu; Sheung-Tat Fan; Chung-Mau Lo; Irene Oi-Lin Ng; Ronnie Tung-Ping Poon; John Wong
Journal:  Arch Surg       Date:  2003-01

9.  Treatment and prognosis of hepatocellular carcinoma: a population based study in France.

Authors:  Frédéric Borie; Anne-Marie Bouvier; Astrid Herrero; Jean Faivre; Guy Launoy; Patricia Delafosse; Michel Velten; Antoine Buemi; Jun Peng; Pascale Grosclaude; Brigitte Trétarre
Journal:  J Surg Oncol       Date:  2008-12-01       Impact factor: 3.454

10.  Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.

Authors:  Kazuaki Shimada; Tsuyoshi Sano; Yoshihiro Sakamoto; Minoru Esaki; Tomoo Kosuge; Hidenori Ojima
Journal:  World J Surg       Date:  2007-10       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.